Bernard Lipman

Array ( [id] => 17685714 [patent_doc_number] => 20220193006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => COMPOSITIONS FOR EFFECTIVE MANAGEMENT OF FIBROBLAST-LIKE SYNOVIOCYTES MEDIATED RHEUMATOID ARTHRITIS [patent_app_type] => utility [patent_app_number] => 17/552535 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6480 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18806786 [patent_doc_number] => 20230381117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => ANTI-OBESITY POTENTIAL OF BISDEMETHOXYCURCUMIN COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/265903 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5066 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20200359 [patent_doc_number] => 12403124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-02 [patent_title] => Central nervous system health supplement [patent_app_type] => utility [patent_app_number] => 17/644069 [patent_app_country] => US [patent_app_date] => 2021-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7081 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17644069 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19018809 [patent_doc_number] => 20240074980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => FORMULATIONS FOR NON-PARENTERAL ADMINISTRATION OF EXOSOMES [patent_app_type] => utility [patent_app_number] => 18/256021 [patent_app_country] => US [patent_app_date] => 2021-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17996 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17503290 [patent_doc_number] => 20220096392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => EDDS CHELATED NANOCERIA WITH CATALASE-LIKE ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/546640 [patent_app_country] => US [patent_app_date] => 2021-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19018860 [patent_doc_number] => 20240075031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => METHOD OF TREATING HEREDITARY HEMORRHAGIC TELANGIECTASIA USING PAZOPANIB [patent_app_type] => utility [patent_app_number] => 18/256304 [patent_app_country] => US [patent_app_date] => 2021-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18256304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17685708 [patent_doc_number] => 20220193000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => KETAMINE TRANSDERMAL DELIVERY SYSTEM [patent_app_type] => utility [patent_app_number] => 17/540695 [patent_app_country] => US [patent_app_date] => 2021-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17540695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17480406 [patent_doc_number] => 20220087910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => COMPOSITE PARTICLES AND METHOD OF PRODUCING THE SAME, PERSONAL CARE PRODUCT, PERSONAL CARE PARTICLES AND METHOD OF PRODUCING THE SAME, PERSONAL CARE ARTICLE, AND PERSONAL CARE COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/539648 [patent_app_country] => US [patent_app_date] => 2021-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18893652 [patent_doc_number] => 20240009137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => ORAL THERAPEUTIC DELIVERY [patent_app_type] => utility [patent_app_number] => 18/254983 [patent_app_country] => US [patent_app_date] => 2021-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18503554 [patent_doc_number] => 11701344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-18 [patent_title] => Bendamustine pharmaceutical compositions [patent_app_type] => utility [patent_app_number] => 17/532874 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 16314 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18893670 [patent_doc_number] => 20240009155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => USE OF SHORT CHAIN FATTY ACIDS IN CANCER PREVENTION [patent_app_type] => utility [patent_app_number] => 18/252222 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19742 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18252222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18050619 [patent_doc_number] => 11523984 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-12-13 [patent_title] => Compositions and methods of administering baclofen [patent_app_type] => utility [patent_app_number] => 17/525298 [patent_app_country] => US [patent_app_date] => 2021-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9750 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19134591 [patent_doc_number] => 11969500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Implantable depots for the controlled release of therapeutic agents [patent_app_type] => utility [patent_app_number] => 17/454320 [patent_app_country] => US [patent_app_date] => 2021-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 58 [patent_no_of_words] => 44934 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17454320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19430795 [patent_doc_number] => 20240299293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => Oral rinse, nasal spray and methods for prevention of COVID-19 by lowering viral load of COVID-19 [patent_app_type] => utility [patent_app_number] => 18/143154 [patent_app_country] => US [patent_app_date] => 2021-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12780 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18143154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18842529 [patent_doc_number] => 20230404933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => NON-CATIONIC SOFT POLYPHENOL NANOCAPSULES FOR EFFECTIVE SYSTEMIC DELIVERY OF SMALL INTERFERING RNA (siRNA) FOR CANCER TREATMENT [patent_app_type] => utility [patent_app_number] => 18/034969 [patent_app_country] => US [patent_app_date] => 2021-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19668 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18034969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18806890 [patent_doc_number] => 20230381223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => ORAL PYROPHOSPHATE FOR USE IN REDUCING CALCIFICATION [patent_app_type] => utility [patent_app_number] => 18/031755 [patent_app_country] => US [patent_app_date] => 2021-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17519266 [patent_doc_number] => 20220105114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => METHODS FOR TREATING CHEMORESISTANT CANCER-INITIATING CELLS [patent_app_type] => utility [patent_app_number] => 17/499648 [patent_app_country] => US [patent_app_date] => 2021-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19883096 [patent_doc_number] => 12268780 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-04-08 [patent_title] => Transparent water nanolipid fluid (DNLF) dispersions and method of preparation using a twin screw extruder [patent_app_type] => utility [patent_app_number] => 17/497819 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12914 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18656043 [patent_doc_number] => 20230301909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => NICOTINAMIDE-ENCAPSULATING MICELLES, AND PREGNANCY-INDUCED HYPERTENSION SYNDROME THERAPY COMPOSITION CONTAINING NICOTINAMIDE-ENCAPSULATING MICELLES [patent_app_type] => utility [patent_app_number] => 18/030832 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17368173 [patent_doc_number] => 20220023225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => SOFT SHELL GELATIN CAPSULES INCORPORATING IMMEDIATE AND EXTENDED RELEASE DOSAGE FORMS AND METHODS OF MANUFACTURING [patent_app_type] => utility [patent_app_number] => 17/483365 [patent_app_country] => US [patent_app_date] => 2021-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11376 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483365 [rel_patent_id] =>[rel_patent_doc_number] =>)